Position in RARE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,380,000
+$1,573,955 QoQ
Shares Held
400,000
+35.2% QoQ
Ownership
0.406%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Newtyn Management, LLC holds $110,545,509 across 7 Biotechnology names. RARE ranks #3 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TBPH |
Theravance Biopharma, Inc.
|
4,841,629 | $78,579,638 | |
| 2 | RCKT |
Rocket Pharmaceuticals, Inc.
|
3,165,900 | $11,333,922 | |
| 3 | RARE |
Ultragenyx Pharmaceutical Inc.
This page
|
400,000 | $8,380,000 | |
| 4 | ATAI |
AtaiBeckley Inc.
|
1,781,703 | $6,307,228 | |
| 5 | MREO |
Mereo BioPharma Group plc
|
7,079,056 | $2,336,088 | |
| 6 | WVE |
Wave Life Sciences Ltd.
|
300,000 | $2,175,000 | |
| 7 | QURE |
uniQure N.V.
|
87,684 | $1,433,633 |
All Filings in RARE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,380,000 | 400,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,806,045 | 295,915 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||